| August
15, 2002 © |
Paul J. Breaux completed
Pharmacy School in 1965. After practicing pharmacy
for several years, he entered L.S.U. Law School,
graduating in 1972, and he has practiced law since
then. His practice is located in Lafayette, Louisiana. |
When the original HIPAA Privacy Rule was published in December
of 2000, most in health care worried that the restrictions
on the use and disclosure of protected health information
("PHI") prohibited many common communications and
practices. Some feared, for example, they would not be able
to have confidential conversations with patients if there
was any possibility at all the conversation could be overheard.
Others felt the strict standards in the privacy rule did not
make allowances for certain activities and communications
that are essential to the care and treatment of patients.
In the preamble to the August 14, 2002, modifications to
the Privacy Rule, however, HHS clarified it had not intended
to hamper traditional customary and necessary health care
communications or practices, and the August 2002 final amendments
add a new section to the Privacy Rule that explicitly permits
certain “incidental uses and disclosures.”
Incidental uses and disclosures are defined by HHS in the
preamble to the modifications as secondary uses or disclosures
that: (1) cannot be reasonably prevented; (2) are limited
in nature; and (3) occur as a by-product of an otherwise permissible
use or disclosure. Examples of incidental disclosures are
when a patient or other person happens to see individually
identifiable health information of other patients on sign-in
sheets in waiting rooms of clinics or physicians' offices,
on patient charts at bedside, or on empty prescription vial
labels.
Another example would be that a physician’s office
may call out a patient’s name in a waiting room, and
a pharmacist or clerk may call out a person’s name when
his or her prescription is filed and ready so long as the
information disclosed is appropriately limited. Also, doctors
can confer at a nurse’s station wit,hout fear of being
in violation of the rule if overheard by a passerby. And,
provided reasonable safeguards and appropriate minimum necessary
standards are in place, a pharmacist should be able to confer
with a patient in his/her pharmacy without fear of being in
violation of the rule.
Incidental uses and disclosures of PHI thus are permissible,
but only to the extent that reasonable safeguards are in place
to minimize such disclosures, and, where applicable, the minimum
necessary standard has been implemented. The modification
does not, however, excuse erroneous uses or disclosures or
those that result from neglect or carelessness. The concept
is that covered entities are required to protect PHI with
a minimum standard of care. As long as that standard of care
is maintained, then a covered provider will be in compliance
even in the event of an incidental disclosure or use of PHI.
|
|